Concepedia

Shi-Liang Gui

SG

7

Publications

273

Citations

7

H-Index

2013

Active since

Affiliations

First Affiliated Hospital of Jiamusi University(Current)

Jiamusi University

Hebei Medical University

Third Hospital of Hebei Medical University

Xuzhou Cancer Hospital

Shi-Liang Gui is an author at First Affiliated Hospital of Jiamusi University specializing in tumor biology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2013–2018

7

Publications

7

Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance

Bauer John J., Dong-xu Zhao, L. Liu et al. · Neoplasma · 2018 · 86 citations · Full text

, , +14

Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer

Shi-Liang Gui, Lichen Teng, Shuqiu Wang et al. · International Urology and Nephrology · 2016 · 60 citations

, , +7

Effects of ganoderic acid A on lipopolysaccharide‑induced proinflammatory cytokine release from primary mouse microglia cultures

Bao‐Jin Chi, Shuqiu Wang, Sheng Bi et al. · Experimental and Therapeutic Medicine · 2017 · 32 citations · Full text

Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer

Zhenguo Luo, Zhigang Li, Shi-Liang Gui et al. · Journal of International Medical Research · 2013 · 28 citations · Full text

Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer

Ying-Li Lin, Shi-Liang Gui, Jianguo Ma · Oncology Letters · 2015 · 27 citations · Full text

, , +13

Rows per page

1–5 of 7